“Just getting the tube down is a problem.”
Dr. Ilan Youngster, a fellow in pediatric infectious diseases at Massachusetts General Hospital and one of the scientists involved in the study, said a written statement released by the hospital:
“Numerous reports have shown that FMT is effective in treating active C. difficile infection and preventing recurrences in patients whose infections failed to respond to standard treatments. The procedures that have been used before–colonoscopies, nasogastric tubes, even enemas–all have potential risks and discomforts for patients.”
The researchers explained that the pill wouldn’t require invasive procedures, and would be less likely to cause vomiting. Inside the capsule are human feces – strained, centrifuged and frozen. They added that donors wouldn’t have to be standing by if the pills were frozen.
It’s very important to find the donor in the right time to avoid a delay in the transplant. Otherwise, the cost will certainly be higher than with convention treatment.
Dr. Youngster added:
“Many people can be carriers of bacteria, viruses, and parasites that are shed in their stools, but have no symptoms, It’s not enough to know your donor and just ask how he or she feels, as some websites suggest. In any form, this procedure should only be performed under strict medical supervision with material from thoroughly screened donors.”The gastroenterologist, Dr. Colleen Kelly, who was not involved in the study, said:
“Capsules are going to replace the way we’ve been doing this. You have to find a donor, have to screen a donor. If you can just open a freezer and take out a poop pill, that’s wonderful.”The study was published in the Journal of the American Medical Association (JAMA) on October 11 after it was tested and successfully treated many patients. Although, the pills are not being marketed yet, the authors of the study expressed their readiness to make them available for those in need.